Daiichi Sankyo reported JPY116.06B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Astellas Pharma JPY 182.02B 53.22B Sep/2026
Chugai Pharma JPY 193.44B 23.07B Sep/2026
Daiichi Sankyo JPY 116.06B 14.46B Jun/2026
Eisai JPY 25.94B 8.21B Sep/2026
Kyowa Hakko Kirin JPY 34.07B 19.84B Sep/2026
M3 JPY 17.84B 17.47B Sep/2026
Otsuka Holdings JPY 174.82B 14.19B Sep/2026
Shionogi JPY 69.31B 18.48B Sep/2026
Sumitomo Dainippon JPY 28.97B 27.16B Sep/2026
Takeda JPY 369.75B 5.29B Sep/2026
Terumo JPY 8.62B 108.05B Sep/2026